Physician profile
Danielle Krause
NPI 1396276051
$2,133.54
in general payments reported to CMS, 2019-2025
15 companies · $841 in 2025
The $841 reported for 2025 was more than what a typical Gynecologic Oncology provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $74.99 · 2023: $1,085 · 2024: $132 · 2025: $841.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,059 · Education: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,058.55 |
| Education | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,028.98 | 2023 | Davinci Xi, Da Vinci Surgical System |
| Merck Sharp & Dohme LLC | $358.59 | 2023-2025 | Lynparza, Keytruda, Keytruda Qlex |
| Astrazeneca Pharmaceuticals LP | $137.95 | 2021-2025 | Lynparza, Enhertu |
| Daiichi Sankyo INC. | $126.60 | 2023-2025 | Enhertu |
| Eisai INC. | $106.92 | 2024-2025 | |
| Tempus Ai, INC | $85.52 | 2025 | Xt Cdx |
| Astellas Pharma US INC | $52.93 | 2025 | Veozah |
| Abbvie INC. | $46.59 | 2025 | |
| Mimedx Group, INC. | $42.29 | 2025 | |
| Glaxosmithkline, LLC. | $37.64 | 2025 | Zejula, Jemperli |
| Caris Mpi, INC. | $34.50 | 2025 | Mi Cancer Seek |
| Ethicon US, LLC | $25.36 | 2025 | Ethicon |
| Pfizer INC. | $19.44 | 2025 | |
| Seagen INC. | $15.56 | 2023 | Tukysa |
| Puma Biotechnology, INC. | $14.67 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Krause listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.